They're told to eat better, to make an effort. Except they're already doing that.
For decades, a condition called lipoedema has quietly shaped the lives of roughly one in ten women worldwide — causing pain, swelling, and a body that resists every conventional remedy — yet medicine has largely met it with silence or blame. Like endometriosis before it, lipoedema reveals how conditions that fall outside the male-dominated medical gaze can go unnamed for generations, leaving patients to carry both the physical burden and the moral accusation that they brought it upon themselves. Only now, slowly, is the condition beginning to find its language — in research journals, in patient associations, and in the quiet recognition that passes between women on social media who finally see themselves in each other's stories.
- Women with lipoedema spend an average of twenty years seeking a correct diagnosis, enduring dismissal, misdiagnosis, and the repeated instruction to simply eat less and move more.
- The condition — painful, progressive, and unresponsive to diet or exercise — erodes not just mobility but mental health, driving many patients toward eating disorders and depression born of unearned guilt.
- Conservative treatments like compression garments and lymphatic drainage offer relief for milder cases, but severe lipoedema often demands expensive surgical intervention that national healthcare systems refuse to cover.
- Women are crowdfunding tens of thousands of euros and taking out personal loans to access surgery that researchers now acknowledge can meaningfully restore quality of life — a gap between evidence and policy that patient advocates are fighting to close.
- France rejected a formal application to fund lipoedema treatment in 2025, citing insufficient data, while advocates draw a direct parallel to endometriosis and vow to reapply in 2028 as research accumulates.
Aurelie Hamon spent three decades watching her legs accumulate fat that no diet or trainer could touch. Walking more than twenty minutes became an ordeal of heaviness and tightening. Doctors told her to try harder. It was only at 47, scrolling through social media, that she encountered other women describing her exact experience — and learned the word for it: lipoedema.
Lipoedema is a chronic condition in which fat builds up abnormally in the legs and sometimes arms, entirely independent of weight or lifestyle. It causes pain, disproportionate swelling, and easy bruising. Research suggests it affects around one in ten women, though the true figure is likely higher, since it is routinely mistaken for obesity or lymphedema. First described in 1940, it was not officially recognized as a disease in France until 2018. Pascale Etchebarne, who leads a French patient association, says women typically wait twenty years for a correct diagnosis — time in which many develop eating disorders and depression, having internalized the message that their body is a personal failure.
The condition's causes remain poorly understood. Hormones appear central, with symptoms often emerging or worsening at puberty, pregnancy, or menopause. Genetics and inflammation also play a role. Treatment starts conservatively: anti-inflammatory diet, compression clothing, lymphatic drainage. For Denise, a 34-year-old at an early stage, this protocol reduced her swelling and stopped her bruising. But for more advanced cases, therapeutic liposuction is often the only meaningful option — and it is almost never covered by public health systems.
Hamon crowdfunded nearly thirty thousand euros for surgery on her thighs and calves after paying out of pocket for her arms in Germany. A 25-year-old named Margo Chinea took out a thirteen-thousand-euro loan for her operation. Both report transformative results: pain gone, mobility restored. A paper published this year in Nature Communications affirmed that lipoedema surgery should be considered when it can significantly improve quality of life.
Yet the system has not caught up. French health authorities rejected Etchebarne's application for coverage in 2025, citing a lack of sufficient data. She is undeterred, drawing comfort from endometriosis — another women's condition that took twenty years to gain recognition. She plans to reapply in June 2028. Until then, women like Hamon and Chinea continue navigating a medical world that has not yet fully learned to see them.
Aurelie Hamon spent decades chasing a solution to a problem her body seemed determined to keep. Her legs accumulated fat with relentless efficiency, beginning in her teenage years, and no amount of discipline could reverse it. Walking more than twenty minutes left her legs feeling impossibly heavy, a tightening sensation spreading through them until she had to stop. She tried diet after diet. She hired a personal trainer. The trainers were baffled. The doctors were dismissive. They told her to exercise more, eat less—the standard prescription for someone whose body wasn't cooperating with the usual rules.
Then one afternoon, scrolling through social media, Hamon encountered women describing something that matched her experience exactly. They called it lipoedema. She was 47 years old. She had been living with this for three decades without a name for it.
Lipoedema is a chronic condition in which fat accumulates abnormally—usually in the legs, sometimes in the arms—independent of a person's weight or lifestyle. It causes pain that can make ordinary movement difficult. It creates a disproportionate body shape. It causes swelling. The skin bruises easily. Research suggests it affects roughly one in ten women worldwide, though the true number may be higher because the condition is routinely misdiagnosed as something else: obesity, or lymphedema, or simply the result of not trying hard enough. The medical establishment has largely overlooked it, much as it overlooked endometriosis for decades. Lipoedema is almost exclusively a women's condition, and it has been treated accordingly—with skepticism, with blame, with the assumption that the problem lies not in the body but in the patient's willpower.
No one knows what causes lipoedema. Hormones appear to play a central role; the condition often emerges or worsens during puberty, pregnancy, or menopause. Genetic factors matter. Inflammation matters. But the underlying mechanism remains mysterious. The condition was first described in 1940. It wasn't officially recognized as a disease in France until 2018. For Hamon, diagnosis took a year of appointments with a vascular specialist. Pascale Etchebarne, who leads a French association dedicated to lipoedema, reports that patients typically wait twenty years before receiving a correct diagnosis. In that time, many develop eating disorders or depression. They internalize the message they've been given repeatedly: that they are failing, that they are not trying hard enough, that their body is a personal failure rather than a medical condition.
Treatment begins conservatively. Michele Cazaubon, a French angiologist, describes the standard approach: an anti-inflammatory diet, regular physical activity, compression clothing, and lymphatic drainage. Denise, a 34-year-old with stage 1 lipoedema, committed to this protocol. She eliminated alcohol and sugar. She walks eight to ten thousand steps daily and does three hours of strength training each week. She drinks a liter and a half of water. The swelling in her legs has decreased. The bruising has stopped. For her, the conservative approach worked.
For more severe cases, therapeutic liposuction offers relief. But the surgery is expensive and rarely covered by national healthcare systems. Hamon underwent liposuction on her arms in Germany, then launched a crowdfunding campaign to raise nearly thirty thousand euros for surgery on her thighs and calves. Margo Chinea, a 25-year-old in France, took out a loan for thirteen thousand euros to pay for her operation. The surgery is not cosmetic; it is therapeutic. Hamon reports that her pain vanished and her mobility returned. A major research paper published in Nature Communications this year acknowledged that lipoedema reduction surgery should be considered when it could meaningfully improve quality of life.
Yet the condition remains systematically underrecognized and underfunded. Last year, Etchebarne's association submitted an application to French health authorities requesting that lipoedema treatment be covered by the national healthcare system. The application was rejected. The authorities cited insufficient scientific data. They said they were waiting for results from ongoing studies. Etchebarne remains undeterred. She notes that endometriosis took twenty years to gain recognition; lipoedema might take ten. She plans to submit a new application in June 2028, once more research has accumulated. For now, women like Hamon and Chinea continue to navigate a medical system that does not yet see them.
Citas Notables
Walking for more than 20 minutes was impossible without feeling extremely heavy and a tightening sensation.— Aurelie Hamon, 47-year-old French sales representative with lipoedema
Patients are diagnosed after 20 years of medical uncertainty, often suffering from eating disorders or depression because they feel intense guilt.— Pascale Etchebarne, head of a French lipoedema association
La Conversación del Hearth Otra perspectiva de la historia
Why did it take Aurelie Hamon so long to get a diagnosis when the condition was first described in 1940?
Because lipoedema was described, but not believed in. For decades it lived in medical literature as a curiosity, not a disease. In France it wasn't officially recognized until 2018. Doctors saw fat on women's legs and assumed the usual culprit—diet, exercise, willpower. The condition didn't fit the framework they had.
So patients were essentially being gaslit by the medical system.
Repeatedly. For twenty years on average. A woman would say her legs hurt, and a doctor would say eat less. She'd say I've tried every diet, and the doctor would say try harder. The guilt accumulates. Some develop eating disorders. Some develop depression. The condition itself causes pain and swelling, but the medical response causes psychological damage.
Why is it almost exclusively a women's condition?
Hormones. It emerges or worsens during puberty, pregnancy, menopause—the moments when women's hormonal systems shift dramatically. But the real answer is we don't know. The condition has been understudied precisely because it affects women. If it affected men at the same rate, we'd probably understand it much better by now.
The surgery costs thousands of euros and isn't covered. How is that sustainable?
It isn't. Women are taking out loans or crowdfunding. A 25-year-old shouldn't have to borrow thirteen thousand euros to treat a medical condition. The authorities say they need more data before covering it. But you can't generate data if you don't fund research. It's a circular problem.
What gives you hope that this changes?
Etchebarne. She's already fought for recognition once and won. She knows it took endometriosis twenty years. She's planning her next application for 2028. She's not waiting for permission. She's building the case.